公司資料
NovoCure Limited 股價、新聞與催化劑
- 股票代碼:
- NVCR
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Switzerland
股票表現
16.76 USD (-1.99%)
收盤價
最後更新: 2026年8月24日
1.83B USD
市值
股價為何變動
As of Aug 24, 2026, NVCR closed down 1.99% at $16.76. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
NovoCure is a medical technology company focused on tumor treating fields, a non-invasive cancer treatment modality. Its business is centered on device-based oncology treatment rather than pharmaceuticals.
所在地與產業分類
NovoCure is headquartered in Switzerland and listed on NASDAQ. It sits in oncology medtech rather than biotechnology.
商業模式特徵
The company depends on adoption of tumor treating fields, reimbursement, and clinical workflow integration. Investors watch usage growth, market expansion, and the breadth of oncology indications.
生技產業定位
NovoCure occupies a unique device-oncology niche within healthcare. It is not biotech, but it is highly relevant to cancer treatment innovation.
未來催化劑
- NovoCure’s catalysts are TTFields adoption, reimbursement, and continued execution across tumor types. The company’s stock usually responds when utilization broadens and evidence strengthens.
近期新聞
- 01
- 02
- 03
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。